Satohap Spray
FDA Label NDC 49873-068

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sato Pharmaceutical Co., Ltd. for the product Satohap (NDC 49873-068). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - when using, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredients
dl-Camphor 5%
l-Menthol 4%
Methyl salicylate 10%

Otc - Purpose

Purpose
dl-Camphor    External analgesic
l-Menthol        External analgesic
Methyl salicylate    External analgesic

Indications & Usage

Uses   temporary relieves minor aches and pains of muscles and joints due to
■ backache   ■ arthritis   ■ strains   ■ bruises   ■sprains

Warnings


For external use only


Dosage & Administration

Directions
■ adults and children 2 years of age and over: Hold can upright and spray until wet. Apply to affected area not more than 3 to 4 times daily.
■ children under 2 years of age: Do not use and ask a doctor.

Inactive Ingredient

Inactive ingredients
fragrance, phenylethyl alcohol, alcohol, propylene glycol, LPG

* Please review the disclaimer below.